PRETARGETED Y-90 THERAPY: PHARMACOKINETICS AND THERAPEUTIC RATIO IN BALB/C MICE WITH KHJJ MOUSE ADENOCARCINOMA USING MAB 2D12.5 AND Y-88 JANUS DOTA